Comment on: suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir.
Anderson
Peter L
PL
Kakuda
Thomas N
TN
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D016049:Didanosine / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D063065:Organophosphonates / Q000627:therapeutic use*; D011683:Purine-Nucleoside Phosphorylase / Q000037:antagonists & inhibitors; D000068698:Tenofovir
D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D011683:Purine-Nucleoside Phosphorylase; D000225:Adenine; D016049:Didanosine